Up to $850 million will be accepted for purchase. CHS has accepted tendered notes on a prorated basis, and CHS will make an announcement when the cash tender offer is complete.
In December, CHS completed a cash tender offer of $1 billion of these same senior notes, which totaled roughly $2.8 billion previously.
More Articles on CHS:
CHS Funds Renovations at Recently Acquired Pennsylvania Hospitals
CHS Pursues More Debt Refinancing
CHS, West Tennessee Healthcare Settle Long-Term Antitrust Dispute
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit